Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Newly Diagnosed Chemotherapy Naïve Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. The Observational ROADMAT-CAT-MM Study

Autor:	Ismail Elalamy, Despina Fotiou, Grigoris T. Gerotziafas, Evangelos Terpos, Annette K. Larsen, Kimon Stamatelopoulos, Efstathios Kastritis, Meletios A. Dimopoulos, Theodora Psaltopoulou, Patrick Vandreden, Loula Papageorgiou, Maria Gavriatopoulou, Theodoros N. Sergentanis
Rok vydání:	2018
Předmět:	Oncology Cancer Research medicine.medical_specialty business.industry Hematology Newly diagnosed medicine.disease Internal medicine medicine Cancer associated thrombosis Identification (biology) Observational study business Clinical risk factor Multiple myeloma Chemotherapy naive
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 18:S235-S236
ISSN:	2152-2650
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0ae8e2c4ffddff504f8d0a7d1b6c9ea8 https://doi.org/10.1016/j.clml.2018.07.121 Zobrazit plný text záznamu Full Text from ScienceDirect